tiprankstipranks
Zelira Therapeutics (ZLDAF)
OTHER OTC:ZLDAF
US Market
Holding ZLDAF?
Track your performance easily

Zelira Therapeutics (ZLDAF) Technical Analysis

17 Followers

Technical Sentiment

Overall Consensus
Neutral
9Bullish
6Neutral
7Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Zelira Therapeutics’s (ZLDAF) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Zelira Therapeutics is a Sell.
Zelira Therapeutics’s (ZLDAF) 20-Day exponential moving average is 0.39, while Zelira Therapeutics’s (ZLDAF) share price is $0.4, making it a Buy.
Zelira Therapeutics’s (ZLDAF) 50-Day exponential moving average is 0.41, while Zelira Therapeutics’s (ZLDAF) share price is $0.4, making it a Sell.

Zelira Therapeutics (ZLDAF) Pivot Points

Jan 19, 2025, 07:36 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.28
0.32
0.36
0.40
0.44
0.48
0.52
Fibonacci
0.32
0.35
0.37
0.40
0.43
0.45
0.48
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Zelira Therapeutics (ZLDAF) Moving Averages

Jan 19, 2025, 07:36 AM
Period
Simple
Exponential
MA5
0.40Buy
0.40Buy
MA10
0.39Buy
0.39Buy
MA20
0.39Buy
0.39Buy
MA50
0.41Sell
0.41Sell
MA100
0.46Sell
0.43Sell
MA200
0.43Sell
0.44Sell
Zelira Therapeutics’s (ZLDAF) 10-Day exponential moving average is 0.39, while Zelira Therapeutics’s (ZLDAF) share price is $0.4, making it a Buy.
Zelira Therapeutics’s (ZLDAF) 100-Day exponential moving average is 0.43, while Zelira Therapeutics’s (ZLDAF) share price is $0.4, making it a Sell.
Zelira Therapeutics’s (ZLDAF) stock price is $0.4 and Zelira Therapeutics’s (ZLDAF) 50-day simple moving average is 0.41, creating a Sell signal.
Zelira Therapeutics’s (ZLDAF) stock price is $0.4 and Zelira Therapeutics’s (ZLDAF) 100-day simple moving average is 0.46, creating a Sell signal.
Zelira Therapeutics’s (ZLDAF) stock price is $0.4 and Zelira Therapeutics’s (ZLDAF) 200-day simple moving average is 0.43, creating a Sell signal.

Zelira Therapeutics (ZLDAF) Technical Indicators

Jan 19, 2025, 07:36 AM
Name
Value
Implied Action
RSI (14)
51.41
Neutral
STOCH (9,6)
48.03
Neutral
STOCHRSI (14)
48.03
Neutral
MACD (12,26)
>-0.01
Sell
ADX (14)
35.84
Neutral
Williams %R
-48.39
Buy
CCI (14)
49.63
Neutral
ATR (14)
0.07
-
Ultimate Oscillator
49.30
Neutral
ROC
14.29
Buy
Zelira Therapeutics’s (ZLDAF) Relative Strength Index (RSI) is 51.41, creating a Neutral signal.
Zelira Therapeutics’s (ZLDAF) Trend Strength Indicator (ADX) is 35.84, creating a Neutral signal.
Zelira Therapeutics’s (ZLDAF) Commodity Channel Index (CCI) is 49.63, creating a Neutral signal.
Zelira Therapeutics’s (ZLDAF) Price Rate of Change (ROC) is 14.29, creating a Buy signal.

FAQ

Is ZLDAF a Buy, Hold, or Sell?
Based on ZLDAF’s technical indicators, ZLDAF is a Hold.
    What is ZLDAF’s RSI (14)?
    ZLDAF’s RSI (14) is 51.41, which suggests ZLDAF is a Neutral.
      What is ZLDAF’s MACD?
      ZLDAF’s MACD is >-0.01, which suggests ZLDAF is a Sell.
        What is ZLDAF’s 5-day moving average?
        ZLDAF’s 5-day moving average is 0.40, which suggests ZLDAF is a Buy.
          What is ZLDAF’s 20-day moving average?
          ZLDAF 20-day moving average is 0.39, which suggests ZLDAF is a Buy.
            What is ZLDAF’s 50-day moving average?
            ZLDAF’s 50-day moving average is 0.41, which suggests ZLDAF is a Sell.
              What is ZLDAF’s 200-day moving average?
              ZLDAF’s 200-day moving average is 0.43, which suggests ZLDAF is a Sell.
                What is ZLDAF’s Williams % R (14)?
                ZLDAF’s Williams % R (14) is -48.39, which suggests ZLDAF is a Buy.
                  What is ZLDAF’s CCI (14)?
                  ZLDAF’s CCI (14) is 49.63, which suggests ZLDAF is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis